203 related articles for article (PubMed ID: 32175770)
1. Novel anthraquinone compounds as anticancer agents and their potential mechanism.
Tian W; Wang C; Li D; Hou H
Future Med Chem; 2020 Apr; 12(7):627-644. PubMed ID: 32175770
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anticancer structure activity relationship investigation of cationic anthraquinone analogs.
Shrestha JP; Fosso MY; Bearss J; Chang CW
Eur J Med Chem; 2014 Apr; 77():96-102. PubMed ID: 24631728
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and screening of novel anthraquinone-quinazoline multitarget hybrids as promising anticancer candidates.
Liang D; Su Z; Tian W; Li J; Li Z; Wang C; Li D; Hou H
Future Med Chem; 2020 Jan; 12(2):111-126. PubMed ID: 31718309
[No Abstract] [Full Text] [Related]
4. Advances in the Discovery of Anthraquinone-Based Anticancer Agents.
Tikhomirov AS; Shtil AA; Shchekotikhin AE
Recent Pat Anticancer Drug Discov; 2018; 13(2):159-183. PubMed ID: 29210664
[TBL] [Abstract][Full Text] [Related]
5. Anthraquinones from the roots of Prismatomeris malayana.
Tuntiwachwuttikul P; Butsuri Y; Sukkoet P; Prawat U; Taylor WC
Nat Prod Res; 2008; 22(11):962-8. PubMed ID: 18629711
[TBL] [Abstract][Full Text] [Related]
6. Anthraquinones and autophagy - Three rings to rule them all?
Deitersen J; El-Kashef DH; Proksch P; Stork B
Bioorg Med Chem; 2019 Oct; 27(20):115042. PubMed ID: 31420258
[TBL] [Abstract][Full Text] [Related]
7. Hydroxyl Group Difference between Anthraquinone Derivatives Regulate Different Cell Death Pathways via Nucleo-Cytoplasmic Shuttling of p53.
Kamil M; Haque E; Mir SS; Irfan S; Hasan A; Sheikh S; Alam S; Ansari KM; Nazir A
Anticancer Agents Med Chem; 2019; 19(2):184-193. PubMed ID: 30370860
[TBL] [Abstract][Full Text] [Related]
8. Anthraquinone: a promising scaffold for the discovery and development of therapeutic agents in cancer therapy.
Siddamurthi S; Gutti G; Jana S; Kumar A; Singh SK
Future Med Chem; 2020 Jun; 12(11):1037-1069. PubMed ID: 32349522
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, DNA binding, and cytotoxicity studies of pyrrolo[2,1-c][1,4]benzodiazepine-anthraquinone conjugates.
Kamal A; Ramu R; Tekumalla V; Khanna GB; Barkume MS; Juvekar AS; Zingde SM
Bioorg Med Chem; 2007 Nov; 15(22):6868-75. PubMed ID: 17822905
[TBL] [Abstract][Full Text] [Related]
10. Design and Syntheses of Novel Fluoroporphyrin-Anthraquinone Complexes as Antitumor Agents.
Yang GL; Zhao SF; Chen NY; Li S
Chem Pharm Bull (Tokyo); 2016; 64(9):1310-4. PubMed ID: 27581635
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, Molecular Docking, and Biological Evaluation of New Emodin Anthraquinone Derivatives as Potential Antitumor Substances.
Li Y; Guo F; Chen T; Zhang L; Wang Z; Su Q; Feng L
Chem Biodivers; 2020 Sep; 17(9):e2000328. PubMed ID: 32627416
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel bis-anthraquinone derivatives and their biological evaluation as antitumor agents.
Taher AT; Hegazy GH
Arch Pharm Res; 2013 May; 36(5):573-8. PubMed ID: 23471561
[TBL] [Abstract][Full Text] [Related]
13. Amides of pyrrole- and thiophene-fused anthraquinone derivatives: A role of the heterocyclic core in antitumor properties.
Tikhomirov AS; Litvinova VA; Andreeva DV; Tsvetkov VB; Dezhenkova LG; Volodina YL; Kaluzhny DN; Treshalin ID; Schols D; Ramonova AA; Moisenovich MM; Shtil AA; Shchekotikhin AE
Eur J Med Chem; 2020 Aug; 199():112294. PubMed ID: 32428792
[TBL] [Abstract][Full Text] [Related]
14. Anthraquinone derivatives induce G2/M cell cycle arrest and apoptosis in NTUB1 cells.
Tu HY; Huang AM; Teng CH; Hour TC; Yang SC; Pu YS; Lin CN
Bioorg Med Chem; 2011 Sep; 19(18):5670-8. PubMed ID: 21852140
[TBL] [Abstract][Full Text] [Related]
15. Anthraquinone-chalcone hybrids: synthesis, preliminary antiproliferative evaluation and DNA-interaction studies.
Marković V; Debeljak N; Stanojković T; Kolundžija B; Sladić D; Vujčić M; Janović B; Tanić N; Perović M; Tešić V; Antić J; Joksović MD
Eur J Med Chem; 2015 Jan; 89():401-10. PubMed ID: 25462255
[TBL] [Abstract][Full Text] [Related]
16. New 1,4-anthracene-9,10-dione derivatives as potential anticancer agents.
Zagotto G; Supino R; Favini E; Moro S; Palumbo M
Farmaco; 2000 Jan; 55(1):1-5. PubMed ID: 10755224
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and cytotoxic effect of 1,3-dihydroxy-9,10-anthraquinone derivatives.
Wei BL; Wu SH; Chung MI; Won SJ; Lin CN
Eur J Med Chem; 2000 Dec; 35(12):1089-98. PubMed ID: 11248407
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, cytotoxic activity and DNA-interaction studies of novel anthraquinone-thiosemicarbazones with tautomerizable methylene group.
Marković V; Janićijević A; Stanojković T; Kolundžija B; Sladić D; Vujčić M; Janović B; Joksović L; Djurdjević PT; Todorović N; Trifunović S; Joksović MD
Eur J Med Chem; 2013 Jun; 64():228-38. PubMed ID: 23644206
[TBL] [Abstract][Full Text] [Related]
19. Microbial Synthesis of Non-Natural Anthraquinone Glucosides Displaying Superior Antiproliferative Properties.
Nguyen TTH; Pandey RP; Parajuli P; Han JM; Jung HJ; Park YI; Sohng JK
Molecules; 2018 Aug; 23(9):. PubMed ID: 30154376
[TBL] [Abstract][Full Text] [Related]
20. Novel Anthraquinone Derivatives as Dual Inhibitors of Topoisomerase 2 and Casein Kinase 2: In Silico Studies, Synthesis and Biological Evaluation on Leukemic Cell Lines.
Kabir A; Tilekar K; Upadhyay N; Ramaa CS
Anticancer Agents Med Chem; 2018; 18(11):1551-1562. PubMed ID: 29683096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
